These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3554702)

  • 1. Clinical comparison of piperacillin and cefamandole in treatment of complicated urinary tract infections.
    Resnick MI; Kursh ED
    Urology; 1987 May; 29(5):570-4. PubMed ID: 3554702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftizoxime in the treatment of urinary tract infections.
    Plimpton HW; Crawford ED
    J Urol; 1982 Dec; 128(6):1231-2. PubMed ID: 6296465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary report comparing piperacillin and carbenicillin for complicated urinary tract infections.
    Swarifi R; Lee M; Ojeda L; Tabib M
    J Urol; 1982 Oct; 128(4):755-8. PubMed ID: 6216344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of aztreonam and cefamandole in the treatment of serious urinary tract infections.
    Tsouroutsoglou W; Sion ML; Stathopoulos GA; Kapoulas S; El-Messidi M; Paradelis AG
    Methods Find Exp Clin Pharmacol; 1983; 5(6):385-90. PubMed ID: 6684719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefamandole and cefazolin in the therapy of complicated urinary tract infections.
    Hoyme U; Madsen PO
    J Infect Dis; 1978 May; 137 Suppl():S100-S102. PubMed ID: 349091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of urinary tract infections in hospitalized patients: a double-blind comparison of cefonicid and cefamandole.
    Cox CE; Jacob LS
    Rev Infect Dis; 1984; 6 Suppl 4():S839-43. PubMed ID: 6395273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of piperacillin versus carbenicillin for complicated urinary tract infections.
    Sharifi R; Lee M; Ojeda L
    Urol Int; 1984; 39(6):345-51. PubMed ID: 6395464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A double blind clinical trial of cefamandole and cefmetazole in complicated urinary tract infections].
    Ohkawa M; Hirano S; Nakashima T; Tokunaga S; Motoi I; Kuroda K; Nakamura T; Iwasa Y; Tajika E; Sakai A; Haginaka T; Kanda S; Kato M; Hasegawa M; Mikawa I; Ikeda A; Shoda R; Ejiri S; Takemae K; Kojima A; Nakajima S; Miyagi T; Ohtaki M; Kitagawa K; Kameda K; Taya T; Okumura R; Shimada K; Kobayashi T; Nango C; Okasho A; Fujita Y; Miyazaki K; Tsukahara K; Kawaguchi S; Tanaka T; Ueno K; Watanabe K
    Jpn J Antibiot; 1983 Jan; 36(1):129-49. PubMed ID: 6341653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timentin versus piperacillin in the treatment of hospitalized patients with urinary tract infections.
    Cox CE
    J Antimicrob Chemother; 1986 May; 17 Suppl C():93-6. PubMed ID: 3636340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefamandole in the treatment of infections due to Enterobacter and indole-positive Proteus.
    Levine LR; McCain E
    J Infect Dis; 1978 May; 137 Suppl():S125-S132. PubMed ID: 649997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aztreonam versus cefamandole in the treatment of urinary tract infections.
    Giamarellou H; Koratzanis G; Kanellakopoulou K; Galanakis N; Papoulias G; el Messidi M; Daikos G
    Chemioterapia; 1984 Apr; 3(2):127-31. PubMed ID: 6543431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aztreonam in the treatment of urinary tract infection.
    Childs SJ
    Am J Med; 1985 Feb; 78(2A):44-6. PubMed ID: 3881948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of piperacillin in the urological field].
    Hayashida S; Kitajima K; Joko K
    Hinyokika Kiyo; 1983 Apr; 29(4):465-76. PubMed ID: 6563846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of ticarcillin plus clavulanate potassium versus piperacillin in the treatment of hospitalized patients with urinary tract infections.
    Cox CE
    Am J Med; 1985 Nov; 79(5B):88-90. PubMed ID: 4073101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piperacillin/tazobactam in the treatment of hospitalized patients with urinary tract infections: an open non-comparative and multicentered trial.
    Sifuentes-Osornio J; Jakob E; Clara L; Durlach R; Dain A; Ruìz-Palacios GM; Barkan L; Lamberghini R; Jáuregui A; Villalobos Y; Sáenz-Aguirre C; de la Cabada FJ; Rodríguez-Toledo A; Zavala-Trujillo I; Gamboa MA; Fuentes del Toro S; Froiler C; Maglio F; Quiroga JV; Rojas JJ; Conde-Carmona I
    J Chemother; 1996 Apr; 8(2):122-9. PubMed ID: 8708743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of i.v. ofloxacin and piperacillin in the treatment of complicated urinary tract infections.
    Schalkhäuser K
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():93-7. PubMed ID: 2286597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of cefotaxime versus cefamandole in prophylaxis for surgical treatment of the biliary tract.
    Wilson SE; Hopkins JA; Williams RA
    Surg Gynecol Obstet; 1987 Mar; 164(3):207-12. PubMed ID: 3103245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of cefamandole nafate.
    Rosett W; Hodges GR; Harms J; Gerjarusak P; Dworzack D; Hinthorn DR; Liu C
    Am J Med Sci; 1977; 274(2):153-61. PubMed ID: 341707
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experience with cefamandole in bacterial infections of children (author's transl)].
    Ichioka T; Miyao M
    Jpn J Antibiot; 1979 Sep; 32(9):901-4. PubMed ID: 501918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summary of worldwide clinical trials of aztreonam in patients with urinary tract infections.
    Swabb EA; Jenkins SA; Muir JG
    Rev Infect Dis; 1985; 7 Suppl 4():S772-7. PubMed ID: 3909336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.